Opioid · Analgesic

Hydromorphone (Dilaudid)

Also called Dilaudid

Reviewed by Alex G, BSN, RN, CEN, CCRN, CMC, NREMT-P · From the Reference tab of the app

Indications

Dosing

Hydromorphone drip card and mL/h converterStart: 0.5–1 mg/h (PADIS range 0.5–3 mg/h)
WhereDose
Other common pushesHydromorphone: 0.2–0.5 mg IV every 5–15 min (about 7 times morphine)
Opioid equianalgesic dosesHydromorphone: 1.5 mg IV = 7.5 mg PO
Other ICU drugsHydromorphone: Use lower doses; metabolite causes neuroexcitation

On the quick cards

Mechanism of action

Hydromorphone is a full μ-opioid agonist with little κ or δ activity, acting through the same Gi/o signaling as morphine: less cAMP, open GIRK potassium channels and closed presynaptic calcium channels in pain pathways. It binds the μ receptor more tightly than morphine (Ki under 1 nM, Volpe 2011), which helps explain its 5–7-fold potency by weight. Its main metabolite, H3G, has no analgesic action but excites neurons when it accumulates.

Pharmacology

Pharmacokinetics

OnsetWithin 5 min IV (Coda 1997)
Peak10–20 min IV (Coda 1997)
DurationAbout 2–4 h IV
Half-lifeAbout 2.3 h IV (label)
DistributionVd about 300 L (about 4 L/kg, label)
Protein binding8–19% (label)
MetabolismLiver glucuronidation (UGT2B7) of over 95% of a dose to H3G; minor 6-hydroxy reduction products; no 6-glucuronide (label)
EliminationUrine, mainly as H3G; about 7% unchanged
Organ failureExposure doubles in moderate and quadruples in severe kidney impairment and rises 4-fold in moderate liver impairment; start at one-quarter to one-half the usual dose (label)
BioavailabilityOral low and variable (about 25–50%), so IV:PO is about 1:5

Chemistry

Adverse effects and cautions

In the one-pagers

Practice Sedation, Pain and Delirium Scales questions free123 exam-style questions with rationales on the topic where Hydromorphone comes up most. No account or download needed.
Practice free in your browser3,800+ exam-style questions with rationales. No account, no ads. Also free on the App Store and Google Play.

Sources

  1. FDA label: Dilaudid Injection (2026)
  2. FDA label: Hydromorphone HCl Injection, Fresenius Kabi (2026)
  3. PubChem: hydromorphone
  4. Coda 1997 (IV onset and potency)

For education and exam preparation only. Follow your institution’s protocols. Typical adult values for study. Follow the order, the label and your institution's protocols.